Sam Tsimikas/X
Aug 23, 2025, 08:14
Sam Tsimikas: NAFCS Score as a Diagnostic Tool for Familial Chylomicronemia Syndrome in Clinical Practice
Sam Tsimikas, Professor of Medicine at the University of California, San Diego, shared a post on X:
“A new paper is out in Lipid Journal validating the NAFCS score for patients with FCS (Familial Chylomicronemia Syndrome- i.e milky plasma) using the Balance genetic data. It will be an alternative method to make the diagnosis of FCS clinically.”
Read the full paper here.
Article: Brief communication: Strong concordance of the North American Familial Chylomicronemia Syndrome Score with a positive genetic diagnosis in patients from the Balance study
Authors: Alan S. Brown, Philippe Moulin, Andrew Dibble, Veronica J. Alexander, Lu Li, Daniel Gaudet, Joseph L. Witztum, Sotirios Tsimikas, Robert A.
Stay updated with Hemostasis Today.
Alan S. Brown
Andrew Dibble
Cardiometabolic Health
Chylomicronemia Syndrome
Clinical Validation
Daniel Gaudet
FCS
Genetic Diagnosis
Health
Hematology
Hemostasis Today
Joseph L. Witztum
Lipid Research
LipidJournal
Lu Li
Medicine
NAFCS
Philippe Moulin
Rare Disorders
Robert A.
Sotirios Tsimikas
Veronica J. Alexander
-
Aug 26, 2026, 14:03Ahmad Masri: The Amyloid Depleter Revolution in ATTR-CM
-
Aug 26, 2026, 13:59David McIntosh: Immunoglobulin Stewardship in the Face of Rising Demand
-
Aug 26, 2026, 13:54Giuseppe Biondi Zoccai: Congratulations to the Next Editor-in-Chief of the EHJ
-
Aug 26, 2026, 13:25Omar Adwan: Abnormal Nuclear Morphology of Neutrophil
-
Aug 26, 2026, 13:05Preventing Thrombosis with WTDay26
-
Aug 26, 2026, 10:09Gemma Figtree: How Well Do We Predict Heart Attack Risk in Women?
-
Aug 26, 2026, 10:06Understanding and Managing Fatigue in ITP – ITP Support Association
-
Aug 26, 2026, 10:04Abdul Muqtadir Abbasi: When a High INR Hides a Thrombotic Cancer
-
Aug 26, 2026, 09:42Mohammed Alo: What’s Wrong With the New Blood Pressure Guidelines?